ScholarIQanswers from OpenAlex
Shinmatsudo Central General Hospital
InstitutionResearch output, impact & collaborations
Shinmatsudo Central General Hospital is a institution indexed in ScholarIQ from OpenAlex.
What is known about Shinmatsudo Central General Hospital?
ScholarIQrecord summary
Shinmatsudo Central General Hospital is a research organisation in Matsudo, JP. OpenAlex records 360 works and 13,079 citations for it.
How many works does Shinmatsudo Central General Hospital have?
ScholarIQindexed works
Shinmatsudo Central General Hospital has 360 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Shinmatsudo Central General Hospital have?
ScholarIQcitation count
Shinmatsudo Central General Hospital has 13,079 citations in the OpenAlex counts ScholarIQ stores.
What is the average h-index at Shinmatsudo Central General Hospital?
ScholarIQavg h-index
Shinmatsudo Central General Hospital has an average h-index of 62 in OpenAlex.
What is the ROR of Shinmatsudo Central General Hospital?
ScholarIQror
The ROR for Shinmatsudo Central General Hospital is on the source record.
What is the OpenAlex record for Shinmatsudo Central General Hospital?
ScholarIQopenalex
The OpenAlex for Shinmatsudo Central General Hospital is on the source record.
Who are the most-cited researchers behind Shinmatsudo Central General Hospital?
ScholarIQtop researchers by citations
What are the most-cited papers on Shinmatsudo Central General Hospital?
ScholarIQmost cited works
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Takuro Saito, Hiroyoshi Nishikawa, Hisashi Wada, Yuji Nagano, Daisuke Sugiyama, Koji Atarashi, Yuka Maeda, Masahide Hamaguchi, Naganari Ohkura, Eiichi Sato, Hirotsugu Nagase, Junichi Nishimura, Hirofumi Yamamoto, Shuji Takiguchi, Takeshi Tanoue, Wataru Suda, Hidetoshi Morita, Masahira Hattori, Kenya Honda, Masaki Mori, Yuichiro� Doki, Shimon Sakaguchi
Anti-CCR4 mAb selectively depletes effector-type FoxP3 <sup>+</sup> CD4 <sup>+</sup> regulatory T cells, evoking antitumor immune responses in humans
Daisuke Sugiyama, Hiroyoshi Nishikawa, Yuka Maeda, Megumi Nishioka, Atsushi Tanemura, Ichiro Katayama, Sachiko Ezoe, Yuzuru Kanakura, Eiichi Sato, Yasuo Fukumori, Julia Karbach, Elke Jäger, Shimon Sakaguchi
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma
Padmanee Sharma, Yu Shen, Sijin Wen, Sachiko Yamada, Achim A. Jungbluth, Sacha Gnjatic, Dean F. Bajorin, Victor E. Reuter, Harry W. Herr, Lloyd J. Old, Eiichi Sato
Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancer
Eri Sugiyama, Yosuke Togashi, Yoshiko Takeuchi, Sayoko Shinya, Yasuko Tada, Keisuke Kataoka, Kenta Tane, Eiichi Sato, Genichiro Ishii, Kōichi Goto, Yasushi Shintani, Meinoshin Okumura, Masahiro Tsuboi, Hiroyoshi Nishikawa
How much of the research on Shinmatsudo Central General Hospital is open access?
ScholarIQopen access share
25%OPEN ACCESS